跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROZLYTREK 200 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ROZLYTREK 200 MG CAPSULAS DURAS
Approved
STANDARD
ROZLYTREK 200 MG CAPSULAS DURAS
Roche Registration Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 27, 2020
Approval ID
c8da6d3950ac509c
Company
Roche Registration Gmbh
Type
Standard
Approval Details
Approval Id
c8da6d3950ac509c
Drug Cima Aemps Name
ROZLYTREK 200 MG CAPSULAS DURAS
Register Number
1201460002
Holder Company Name
Roche Registration Gmbh
Marketing Company Name
Roche Farma S.A.
Holder Company Detail Path
/organization/roche-registration-gmbh
Authorization Date
2020-08-27
Dosage Form
CÁPSULA DURA
Dose
200 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Roche Registration Gmbh
Company Detail Path
/organization/roche-registration-gmbh
Company Information
Pharmaceutical Company Name
Roche Registration GmbH
Country Name
Germany
City Name
grenzach-wyhlen,baden-württemberg,country_de
Address
Emil-Barell-Str. 1
Active Ingredients
ENTRECTINIB
200 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 27, 2020
Approval ID
c8da6d3950ac509c
Type
Standard
Back to CIMA-AEMPS Approvals